Prognostic significance of Bcl-2 and p53 protein expression in stage IIB and IIB squamous cell carcinoma of the cervix

European Journal of Gynaecological Oncology

Volumn 19, Issue 6, 1998, Pages 556-560

  Rajkumar, T ^a   Rajan, S ^b   Baruah, R K ^b   Majhi, U ^b   Selvaluxmi, G ^b   Vasanthan, A ^b  

^a CANCER INSTITUTE WIA   (India)

^b NONE

Author keywords

Bcl 2; Cervical cancer; p53; Prognosis

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ARTICLE; CANCER RADIOTHERAPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIA; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 0032416218     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Huffman B., Liebermann D. A.: "Molecular controls of apoptosis: differentiation/growth arrest primary response genes, proto-oncogencs, and tumour suppressor genes as positive and neaative modulators". Oncogene, 1994, 9, 1807.
2. Wyllie A. H.: "Apoptosis". Dr. J. Cancer, 1993, 67, 205.
3. Kastan M. B., Onyekwere O., Sidaransky D., Vogelstein B., Craig R. W.: "Participation of p53 protein in the cellular response to DNA damage". Cancer Res., 1991, 51, 6304.
4. Yonish-Rouach E., Rensmitzki D., Lotem J., Sachs L., Kimchi A., Oren M.: "Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by Interleukin 6". Nature, 1991, 352, 345.
5. Dexter T. M., Raff M. C., Wyllie A. H. eds.: "The role of apoptosis in develpment, tissue homeostasis and malignancy". Philos. Trans. R. Soc. London Sci: B., 1995, 345 (whole volume).
6. Kernohan N. M., Cox L. S.: "Regulation of apoptosis by Bcl-2 and its related proteins: immunochemical challenges and therapeutic implications". J. Pathol., 1996, 179, 1.
7. Gottschalk A. R., Boise L. H., Thompson C. B., Quintans J.: "Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by Bcl-x but not Bcl-2". Proc. Nail. Acad. Sci. USA, 1994, 91, 3516.
8. Boise L. H., Gonzalez-Garcia M., Postema C. E. et al.: "Bcl-x, a Bcl-2 related gene that functions as a dominant regulator of apoptotic cell death". Cell., 1993, 74, 597.
9. Oltavi Z. N., Milliman C. L., Korsmeyer S. J.: "Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death". Cell., 1993, 74, 609.
10. Nunez G., London L., Hockenbery D., Alexander M., McKearn J. P., Korsmeyer S. J.: "Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines". J. Immunol., 1990, 144, 3602.
11. Hockenbery D., Nunez G., Milliman C, Schreiber R. D., Korsmeyer S. J.: "Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death". Nature, 1990, 348, 334.
12. Hockenbery D., Oltavi Z. N., Yin X-M., Milliman C. L., Korsmeyer S. J.: "Bcl-2 functions in an anti-oxidant pathway to prevent apoptosis". Cell., 1993, 75, 241.
13. Tsujimoto Y., Croce C. M.: "Analysis of the structure, transcripts, and protein products of Bcl-2, the gene involved in human follicular lymphoma". Proc. Null. Acad. Sci USA, 1986, 83, 5214.
14. Hockenbery D., Zutter M., Hickey W., Nahm M., Korsmeyer S. J.: "Bcl-2 protein is topographically restricted in tissues characterised by apoptotic cell death". Proc. Natl. Acad. Sci USA, 1991, 88, 6961.
15. Harmsel B. T., Smedts F., Kuijpers J., Jeunink M., Trimbos B., Ramaekers F.: "Bcl-2 immunoreactivity increases with severity of CIN: a study of normal cervical epithelia, CIN and cervical carcinoma". J. Pathol., 1996, 179, 26.
16. Cancer incidence and mortality in Madras, India 1992, Madras Metropolitan Tumour Registry. National Cancer Registry Programme, Indian Council of Medical Research, Cancer Institute (WIA), Madras, India, 12.
17. Rajkumar T., Majhi U., Malligarjuna V., Shantha V., Gullick W. J.: "Prevalence of c-erbB3 expression in squamous cell carcinomas of the cervix as determined by the monoclonal antibody RTJ2". Int. J. Oncol., 1995, 6, 105.
18. Vojtesek B., Bartek J., Midgley C. A., Lane D. P.: "An immunochemical analysis of the human nuclear phosphoprotein p53: new monoclonal antibodies and epitope mappinc using recombinant p53". J. Immunol. Med., 1992, 151, 237.
19. Lambkin H.A., Mothersill C. M., Kelehan P.: "Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection". J. Pathol., 1994, 772, 13.
20. Tsujimoto Y, Finger L. R., Yunis J., Nowell P. C., Croce C. M.: "Cloning of the chromosome breakpoint of neoplastic B cells with the t(14:18) chromosome translocation". Science, 1984, 226, 1097.
21. Bakhshi A., Jensen J. P., Goldman P. et al.: "Cloning the chromosome breakpoint of t(14:18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18". Cell., 1985, 41, 899.
22. Doglioni C., Dei Tos A. P., Laurino L., Chiarelli C., Barbareschi M., Viale G.: "The prevalence of Bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates with particular reference to estrogen receptor status". Virchow. Arch., 1994, 424, 47.
23. Hashimoto H., Chaterjee S., Berger N. A.: "Inhibition of etoposide (VP-16) - induced DNA recombination and mutant frequency by Bcl-2 protein overexpression". Cancer Res., 1995, 55, 4029.
24. Miyashita T., Reed J. C.: "Bcl-2 oncoprotein blocks chemotherapy induced apoptosis in a leukemia cell line". Blood, 1993, 81, 151.
25. Merritt A. J., Potter C. S., Kemp C. J. et al: "The role of p53 in spontaneous and radiation induced apoptosis in the grastrointestinal tract of normal and p53 deficient mice". Cancer Res., 1994, 54, 614.
26. Haldar S., Negrini M., Monne M., Sabbioni S., Croce C. M.: "Down regulation of Bcl-2 by p53 in breast cancer cells". Cancer Res., 1994, 54, 2095.
27. Miyashita T., Harigai M., Hanada M., Reed J. C.: "Identification of a p53 dependent negative response element in the Bcl-2 gene". Cancer Res., 1994, 54, 3131.
28. zur Hausen H.: "Papillomaviruses as carcinoma viruses". In: "Advances in viral oncology". G. Klein, ed. Raven press, New York, 1989, 1.